Medication Reconciliation for Patients Receiving Care at Dialysis Facilities

Number of patient-months for which medication reconciliation was performed and documented by an eligible professional during the reporting period. 

The medication reconciliation MUST:
• Include the name or other unique identifier of the eligible professional;

AND

• Include the date of the reconciliation;

AND

• Address ALL known home medications (prescriptions, over-the-counters, herbals, vitamin/mineral/dietary (nutritional) supplements, and medical marijuana);

AND

• Address for EACH home medication: Medication name(1), indication(2), dosage(2), frequency(2), route of administration(2), start and end date (if applicable)(2), discontinuation date (if applicable)(2), reason medication was stopped or discontinued (if applicable)(2), and identification of individual who authorized stoppage or discontinuation of medication (if applicable)(2);

AND

• List any allergies, intolerances, or adverse drug events experienced by the patient.
_________________________________________________________________________________
1. For patients in a clinical trial, it is acknowledged that it may be unknown as to whether the patient is receiving the therapeutic agent or a placebo.

2. “Unknown” is an acceptable response for this field.